Impact Factor
3.29
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.35
702 total citations
h5-index
30
h5 depth signal
Cited share
64.0%
194 of 303
Total citations
702
Citation footprint
Metric signal
2.67
External metric anchor
Self-citation
2.1%
15 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,065
China
253
Italy
132
Canada
69
India
63
Citing Fields of Research
Digestive Disorders
1,105
Liver Diseases
463
Inflammatory Bowel Diseases & Infections
343
Liver & Colon Cancer
310
Hepatitis
235
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
10,347
Articles tracked across the journal lifetime
Indexed publication set
303
194 cited publications
Last 12 months
184
15.3 publications/month
Open access share
9.2%
17 OA publications in the last year
Leading citing country
United States
1,065 citing publications
Leading citing field
Digestive Disorders
1,105 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1979-
v1n1, 1979-
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Inflammatory Bowel Diseases & Infections
Liver Diseases
Liver & Colon Cancer
Broad Categories
Gastroenterology
Digestive Disorders
Liver & Colon Cancer
Liver Diseases
Inflammatory Bowel Diseases & Infections
MeSH Descriptors
Gastroenterology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/mcg.0000000000002448
Open DOI
High-Resolution Manometry Assessment of Esophagitis Across Los Angeles Grades Validates Lyon 2.0 Criteria
Introduction: Gastroesophageal reflux disease (GERD) with erosive esophagitis is driven by antireflux barrier (ARB) dysfunction, yet a comprehensive high-resolution manometry (HRM) assessment across Los Angeles (LA) grades is lacking. Th...
02
DOI 10.1097/mcg.0000000000002449
Open DOI
Comparison of the Efficacy of Dexrabeprazole and Rabeprazole in Inhibiting Intragastric and Intraesophageal Acidity in Gastroesophageal Reflux Disease
Background: Proton pump inhibitors (PPIs) are the cornerstone of gastroesophageal reflux disease (GERD) treatment, but concerns regarding their efficacy and side effects persist. Dexrabeprazole, the R(+) enantiomer of rabeprazole, may of...
03
DOI 10.1097/mcg.0000000000002453
Open DOI
GI PCR Versus Stool Culture: Can Positive-Result Cohorts Determine the Preferred Initial Test?
04
DOI 10.1097/mcg.0000000000002424
Open DOI
The Trajectory of Gastrointestinal Symptom Experience Following Fecal Microbiota Transplant for Recurrent Clostridioides Difficile Infection
Introduction: Recurrent Clostridioides difficile infection (rCDI) increases the risk of persistent gastrointestinal symptoms after treatment. Although fecal microbiota transplantation (FMT) effectively prevents CDI recurrence after antib...
05
DOI 10.1097/mcg.0000000000002450
Open DOI
Monoclonal Antibody Therapy in Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory disorder characterized by esophageal eosinophilic infiltration and symptoms of esophageal dysfunction, most notably dysphagia and food impaction. The prevalence of ...
06
DOI 10.1097/mcg.0000000000002436
Open DOI
Wearable Technology and Remote Physiological Monitoring in Inflammatory Bowel Disease: Erratum
Was not provided for this article.
07
DOI 10.1097/mcg.0000000000002437
Open DOI
Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050
Goals: The study aims to analyze and project esophageal cancer trends in China from 1990 to 2023 using GBD 2023 data. Background: Esophageal cancer (EC) remains a major public health challenge in China. Updated evidence on long-term tren...
08
DOI 10.1097/mcg.0000000000002441
Open DOI
Patient Satisfaction and Perceived Stress in Digestive Endoscopy
Objective: To evaluate patient satisfaction and perceived stress among adults undergoing diagnostic digestive endoscopy in Italy and to examine their associations with sociodemographic, clinical, and procedural factors. Background: Patie...
09
DOI 10.1097/mcg.0000000000002440
Open DOI
World Gastroenterology Organisation Practice Guidelines
Significant progress on hepatitis B treatment pathways has been made since the last World Gastroenterology Organisation (WGO) guidelines in 2015. Global elimination targets have been set, prioritizing the prevention of new infections and...
10
DOI 10.1097/mcg.0000000000002446
Open DOI
Gap in Care
Goals: This study evaluated the follow-up rates for incidental hepatic steatosis detected via imaging at an urban safety-net hospital. Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of c...
Bibliographical & Catalog Notes
Print issues ceased with 2022.
Also issued online.
Vol. 8, no. 1 (FEB 1986)19900914 Notice not published Printed on acid-free paper